Potential amelioration of nicotine-induced toxicity by nanocurcumin.
- Published in:
- Drug Development Research, 2018, v. 79, n. 3, p. 119, doi. 10.1002/ddr.21424
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2018 AND VI 79 AND IP 3
Results: 5
1
2
A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
- Published in:
- Drug Development Research, 2018, v. 79, n. 3, p. 129, doi. 10.1002/ddr.21426
- By:
- Publication type:
- Article
3
Novel primary amine diazeniumdiolates--Chemical and biological characterization.
- Published in:
- Drug Development Research, 2018, v. 79, n. 3, p. 136, doi. 10.1002/ddr.21428
- By:
- Publication type:
- Article
4
An updated overview with simple and practical approach for developing in vitro-in vivo correlation.
- Published in:
- Drug Development Research, 2018, v. 79, n. 3, p. 97, doi. 10.1002/ddr.21427
- By:
- Publication type:
- Article
5
The potential of radiolabeled chemotherapeutics in tumor diagnosis: Preliminary investigations with <sup>68</sup>Ga-gemcitabine.
- Published in:
- Drug Development Research, 2018, v. 79, n. 3, p. 111, doi. 10.1002/ddr.21423
- By:
- Publication type:
- Article